Abiopharma

REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone

Compass Minerals Announces S&P Global Ratings Upgrade to B+

Keel Infrastructure Added to Russell 3000® Index

Gilat Receives $43 Million of Additional Sidewinder ESA Orders from Leading In-flight Connectivity Service Provider

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Chong Moi Me

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director / Chief Executive Officer - Ooi Shu Geok

Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale

Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors

IREN Added to Russell 1000 Index

Relmada Therapeutics Joins Russell2000® and Russell 3000® Indexes